Return to CBI Antibody Core Home Page
  Return to Drosophila list
    Return to fruit fly ( Drosophila melanogaster ) list


fruit fly ( Drosophila melanogaster )
Ago2-PIWI


Links to multiple antibodies on this page for Ago2-PIWI:
Ago2-PAZ
Ago2-PIWI

Antibody Name/Abbreviation: Ago2-PAZ
CBI Antibody Core Code: A0698

"Lot" Number: 1 Position: 100(622-721)
% Identical Homology of Target to Mouse Protein: 42% (NP_694818.2| eukaryotic translation initiation factor 2C, 2; GERp95; Piwi/Argonaute family protein meIF2C2; argonaute 2)
Molecular Weight of fusion protein: 38 KDa

Target sequence used to make this antibody:
NTTNLDYSRRFLEPFLRGINVVYTPPQSFQSAPRVYRVNG
LSRAPASSETFEHDGKKVTIASYFHSRNYPLKFPQLHCLN
VGSSIKSILLPIELCSIEEG






Antibody Name/Abbreviation: Ago2-PIWI
CBI Antibody Core Code: A0699

"Lot" Number: 1 Position: 100(1019-1118)
% Identical Homology of Target to Mouse Protein: 42% (NP_694818.2| eukaryotic translation initiation factor 2C, 2; GERp95; Piwi/Argonaute family protein meIF2C2; argonaute 2)
Molecular Weight of fusion protein: 38 KDa

Target sequence used to make this antibody:
EHLRVYKEYRNAYPDHIIYYRDGVSDGQFPKIKNEELRCI
KQACDKVGCKPKICCVIVVKRHHTRFFPSGDVTTSNKFNN
VDPGTVVDRTIVHPNEMQFF






Sequence Name: Ago2-PIWI
Full name: Argonaute 2
UniGene Number: N.A.
Accession Number: NP_730054
Source organism: fruit fly ( Drosophila melanogaster )
Full length size (aa): 1217
NCBI information page: click here

Full length sequence:
MHFPITTPENKKGGQDSAAAPQPQQQQKQQQQRQQQPQQLQQPQQLQQPQ
QLQQPQQQQQQQPHQQQQQSSRQQPSTSSGGSRASGFQQGGQQQKSQDAE
GWTAQKKQGKQQVQGWTKQGQQGGHQQGRQGQDGGYQQRPPGQQQGGHQQ
GRQGQEGGYQQRPPGQQQGGHQQGRQGQEGGYQQRPSGQQQGGHQQGRQG
QEGGYQQRPPGQQQGGHQQGRQGQEGGYQQRPSGQQQGGHQQGRQGQEGG
YQQRPPGQQQGGHQQGRQGQEGGYQQRPPGQQQGGHEQGRQGQEGGYQQR
PSGQQQGGHQQGRQGQEGGYQQRPSGQQQGGHQQGRQGQEGGYQQRPSGQ
QQGGHQQGRQGQEGGYQQRPPGQQPNQTQSQGQYQSRGPPQQQQAAPLPL
PPQPAGSIKRGTIGKPGQVGINYLDLDLSKMPSVAYHYDVKIMPERPKKF
YRQAFEQFRVDQLGGAVLAYDGKASCYSVDKLPLNSQNPEVTVTDRNGRT
LRYTIEIKETGDSTIDLKSLTTYMNDRIFDKPMRAMQCVEVVLASPCHNK
AIRVGRSFFKMSDPNNRHELDDGYEALVGLYQAFMLGDRPFLNVDISHKS
FPISMPMIEYLERFSLKAKINNTTNLDYSRRFLEPFLRGINVVYTPPQSF
QSAPRVYRVNGLSRAPASSETFEHDGKKVTIASYFHSRNYPLKFPQLHCL
NVGSSIKSILLPIELCSIEEGQALNRKDGATQVANMIKYAATSTNVRKRK
IMNLLQYFQHNLDPTISRFGIRIANDFIVVSTRVLSPPQVEYHSKRFTMV
KNGSWRMDGMKFLEPKPKAHKCAVLYCDPRSGRKMNYTQLNDFGNLIISQ
GKAVNISLDSDVTYRPFTDDERSLDTIFADLKRSQHDLAIVIIPQFRISY
DTIKQKAELQHGILTQCIKQFTVERKCNNQTIGNILLKINSKLNGINHKI
KDDPRLPMMKNTMYIGADVTHPSPDQREIPSVVGVAASHDPYGASYNMQY
RLQRGALEEIEDMFSITLEHLRVYKEYRNAYPDHIIYYRDGVSDGQFPKI
KNEELRCIKQACDKVGCKPKICCVIVVKRHHTRFFPSGDVTTSNKFNNVD
PGTVVDRTIVHPNEMQFFMVSHQAIQGTAKPTRYNVIENTGNLDIDLLQQ
LTYNLCHMFPRCNRSVSYPAPAYLAHLVAARGRVYLTGTNRFLDLKKEYA
KRTIVPEFMKKNPMYFV





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.